Invasive network neuromodulation for insular epilepsy: A three‐center retrospective study
Epilepsia · 2026
DOI: 10.1002/epi.70479 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Epilepsia, 2026. Verfasst von Raunak Singh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Deep Brain Stimulation, Insular Cortex. Die Arbeit nennt 18 Literaturangaben. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
To characterize invasive neuromodulation for insular drug‐resistant epilepsy, we retrospectively evaluated 22 patients treated with responsive neurostimulation (RNS; n = 14) or chronic subthreshold stimulation (CSS; n = 8). Stereoelectroencephalography was performed in 20 cases (91%). Median baseline seizure frequency was 10.5/month. Forty‐one percent had prior epilepsy surgery. At year 3, median seizure reduction (MSR) was 83% ( p = .01, Wilcoxon signed‐rank test), with a responder rate (RR) of 77%; MSR was 92% for CSS and 75% for RNS. There were no significant differences in MSR ( p ≥ .4) or RR ( p > .9) when comparing RNS versus CSS. Three patients achieved seizure freedom by year 3. Patients undergoing combined insular–thalamic stimulation ( n = 5) demonstrated an MSR of 84%, 86%, and 88% at 1, 2, and 3 years; seizure reduction in thalamocortical versus cortical‐only stimulation was not different ( p ≥ .1). Parasagittal lead trajectories achieved closer insular proximity than transopercular trajectories ( p < .0001, Mann–Whitney U ‐test). Median charge density at last follow‐up was 1.3 μC/cm 2 . There were no acute surgical complications and all stimulation‐related side effects resolved with programming adjustments. This study expands the limited literature on insular neuromodulation by demonstrating effectiveness of RNS and CSS, suggesting potential benefit from combined thalamocortical targeting, and defining parasagittal trajectories as a surgical approach for optimal lead proximity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Child and Adolescent Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
- Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA.
- Department of Neurology, Columbia University, New York, New York, USA.
ORCID-Profile: Raunak Singh, Nicholas M Gregg, Keith D Starnes, Gamaleldin Osman, Jamie J Van Gompel, Kai J Miller, William O Tatum, Gregory A Worrell, Juan Luis Alcala-Zermeno, Brian N Lundstrom
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Singh, R., Gregg, N. M., Starnes, K. D., Osman, G., Van Gompel, J. J., Miller, K. J., Tatum, W. O., Crepeau, A., Worrell, G. A., Alcala-Zermeno, J. L., & Lundstrom, B. N. (2026). Invasive network neuromodulation for insular epilepsy: A three‐center retrospective study. Epilepsia. https://doi.org/10.1002/epi.70479
Vancouver
Singh R, Gregg NM, Starnes KD, Osman G, Van Gompel JJ, Miller KJ, et al. Invasive network neuromodulation for insular epilepsy: A three‐center retrospective study. Epilepsia. 2026. doi:10.1002/epi.70479
BibTeX
@article{Singh2026,
author = {Singh, Raunak and Gregg, Nicholas M and Starnes, Keith D and Osman, Gamaleldin and Van Gompel, Jamie J and Miller, Kai J and Tatum, William O and Crepeau, Amy and Worrell, Gregory A and Alcala-Zermeno, Juan Luis and Lundstrom, Brian N},
title = {Invasive network neuromodulation for insular epilepsy: A three‐center retrospective study},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70479}
}
EUVIMED